Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.

Baguelin M, Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ.

Vaccine. 2010 Mar 11;28(12):2370-84. doi: 10.1016/j.vaccine.2010.01.002. Epub 2010 Jan 21.

PMID:
20096762
2.

Optimizing infectious disease interventions during an emerging epidemic.

Wallinga J, van Boven M, Lipsitch M.

Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):923-8. doi: 10.1073/pnas.0908491107. Epub 2009 Dec 28.

3.

The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom.

Ghani A, Baguelin M, Griffin J, Flasche S, van Hoek AJ, Cauchemez S, Donnelly C, Robertson C, White M, Truscott J, Fraser C, Garske T, White P, Leach S, Hall I, Jenkins H, Ferguson N, Cooper B.

Version 2. PLoS Curr. 2009 Nov 16 [revised 2010 Jan 1];1:RRN1130. No abstract available.

4.

Distribution of vaccine/antivirals and the 'least spread line' in a stratified population.

Goldstein E, Apolloni A, Lewis B, Miller JC, Macauley M, Eubank S, Lipsitch M, Wallinga J.

J R Soc Interface. 2010 May 6;7(46):755-64. doi: 10.1098/rsif.2009.0393. Epub 2009 Oct 14.

5.

Optimizing influenza vaccine distribution.

Medlock J, Galvani AP.

Science. 2009 Sep 25;325(5948):1705-8. doi: 10.1126/science.1175570. Epub 2009 Aug 20.

6.

Household structure and infectious disease transmission.

House T, Keeling MJ.

Epidemiol Infect. 2009 May;137(5):654-61. doi: 10.1017/S0950268808001416. Epub 2008 Oct 8.

7.

Economic evaluation of human papillomavirus vaccination in the United Kingdom.

Jit M, Choi YH, Edmunds WJ.

BMJ. 2008 Jul 17;337:a769. doi: 10.1136/bmj.a769.

8.

Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.

Mylius SD, Hagenaars TJ, Lugnér AK, Wallinga J.

Vaccine. 2008 Jul 4;26(29-30):3742-9. doi: 10.1016/j.vaccine.2008.04.043. Epub 2008 May 7.

PMID:
18524428
9.

Social contacts and mixing patterns relevant to the spread of infectious diseases.

Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ.

PLoS Med. 2008 Mar 25;5(3):e74. doi: 10.1371/journal.pmed.0050074.

10.
11.

Vaccinating to protect a vulnerable subpopulation.

Dushoff J, Plotkin JB, Viboud C, Simonsen L, Miller M, Loeb M, Earn DJ.

PLoS Med. 2007 May;4(5):e174.

12.

Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger.

Grais RF, Conlan AJ, Ferrari MJ, Djibo A, Le Menach A, Bjørnstad ON, Grenfell BT.

J R Soc Interface. 2008 Jan 6;5(18):67-74.

13.

Comparison of smallpox outbreak control strategies using a spatial metapopulation model.

Hall IM, Egan JR, Barrass I, Gani R, Leach S.

Epidemiol Infect. 2007 Oct;135(7):1133-44. Epub 2007 Jan 12.

14.

Strategies for mitigating an influenza pandemic.

Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS.

Nature. 2006 Jul 27;442(7101):448-52. Epub 2006 Apr 26.

PMID:
16642006
15.

Planning for smallpox outbreaks.

Ferguson NM, Keeling MJ, Edmunds WJ, Gani R, Grenfell BT, Anderson RM, Leach S.

Nature. 2003 Oct 16;425(6959):681-5. Review.

PMID:
14562094
16.

Modelling vaccination strategies against foot-and-mouth disease.

Keeling MJ, Woolhouse ME, May RM, Davies G, Grenfell BT.

Nature. 2003 Jan 9;421(6919):136-42. Epub 2002 Dec 22.

PMID:
12508120
17.

Vaccines and their impact on the control of disease.

McLean AR.

Br Med Bull. 1998;54(3):545-56. Review.

PMID:
10326283
18.

Herd immunity: history, theory, practice.

Fine PE.

Epidemiol Rev. 1993;15(2):265-302. Review. No abstract available.

PMID:
8174658
19.

Directly transmitted infections diseases: control by vaccination.

Anderson RM, May RM.

Science. 1982 Feb 26;215(4536):1053-60.

PMID:
7063839
20.

Supplemental Content

Support Center